Works matching IS 03407004 AND DT 2023 AND VI 72 AND IP 10
Results: 21
Correction to: Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Decoding the genetic links between serum lipidomic profile, amino acid biomarkers, and programmed cell death protein-1/programmed cell death-ligand-1.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3395, doi. 10.1007/s00262-023-03501-8
- By:
- Publication type:
- Article
Successful ex vivo expansion of tumor infiltrating lymphocytes with systemic chemotherapy prior to surgical resection.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3377, doi. 10.1007/s00262-023-03500-9
- By:
- Publication type:
- Article
Immune checkpoint inhibitor treatment of brain metastasis associated with a less invasive growth pattern, higher T-cell infiltration and raised tumor ADC on diffusion weighted MRI.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3387, doi. 10.1007/s00262-023-03499-z
- By:
- Publication type:
- Article
Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3349, doi. 10.1007/s00262-023-03496-2
- By:
- Publication type:
- Article
Circadian pattern subtyping unveiling distinct immune landscapes in breast cancer patients for better immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3293, doi. 10.1007/s00262-023-03495-3
- By:
- Publication type:
- Article
Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3337, doi. 10.1007/s00262-023-03494-4
- By:
- Publication type:
- Article
Melanoma-derived soluble mediators modulate neutrophil biological properties and the release of neutrophil extracellular traps.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3363, doi. 10.1007/s00262-023-03493-5
- By:
- Publication type:
- Article
Good manufacturing practice production of CD34<sup>+</sup> progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3323, doi. 10.1007/s00262-023-03492-6
- By:
- Publication type:
- Article
CD24 is a novel target of chimeric antigen receptor T cells for the treatment of triple negative breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3191, doi. 10.1007/s00262-023-03491-7
- By:
- Publication type:
- Article
Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3243, doi. 10.1007/s00262-023-03490-8
- By:
- Publication type:
- Article
Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3217, doi. 10.1007/s00262-023-03489-1
- By:
- Publication type:
- Article
SIGLEC10<sup>+</sup> macrophages drive gastric cancer progression by suppressing CD8<sup>+</sup> T cell function.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3229, doi. 10.1007/s00262-023-03488-2
- By:
- Publication type:
- Article
Piper nigrum extract suppresses tumor growth and enhances the antitumor immune response in murine models of breast cancer and melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3279, doi. 10.1007/s00262-023-03487-3
- By:
- Publication type:
- Article
Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3309, doi. 10.1007/s00262-023-03486-4
- By:
- Publication type:
- Article
Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and CTSL to predict immunotherapeutic response for lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3259, doi. 10.1007/s00262-023-03485-5
- By:
- Publication type:
- Article
DLGAP5 promotes gallbladder cancer migration and tumor-associated macrophage M2 polarization by activating cAMP.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3203, doi. 10.1007/s00262-023-03484-6
- By:
- Publication type:
- Article
Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3175, doi. 10.1007/s00262-023-03482-8
- By:
- Publication type:
- Article
Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3135, doi. 10.1007/s00262-023-03480-w
- By:
- Publication type:
- Article
Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3149, doi. 10.1007/s00262-023-03476-6
- By:
- Publication type:
- Article
Revealing the impact of CD70 expression on the manufacture and functions of CAR-70 T-cells based on single-cell transcriptomics.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3163, doi. 10.1007/s00262-023-03475-7
- By:
- Publication type:
- Article